At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Exploratory Study to Establish the Dose, Safety and Pathogenicity of a New Influenza A H3N2 Challenge Strain in Healthy Participants 18 to 55 Years of Age
In Brief
A clinical study evaluating Influenza A H3N2 virus dose arm 1, Influenza A H3N2 virus dose arm 2, and 1 other intervention for Influenza A H3N2. Completed, enrolled 33 participants across 1 site.
Detailed Summary
An Exploratory Study to Establish the Dose, Safety and Pathogenicity of a New Influenza A H3N2 Challenge Strain in Healthy Participants 18 to 55 Years of Age In Part A, up to 40 participants will be randomly allocated to one of two groups to be given one of two virus doses (Virus Dose 1 or Virus Dose 2). Based on the outcome of Part A, participants in Part B, may be given Virus Dose 1, Virus Dose 2, or another virus dose (e.g., Virus Dose 3)
Study Details
Timeline
Interventions
Medium dose, approximately 10\^4.5 TCID50/mL
High dose, approximately 10\^5.5 TCID50/mL
TBD, depending on outcome of Part A